Orthofix Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-119.12	-126	-151.4	-19.75	-38.38	2.52
Depreciation & Amortization	74.57	75.96	60.56	32.08	33.1	34.28
Loss (Gain) From Sale of Assets	0.03	2.03	2.3	2.07	-	-
Asset Writedown & Restructuring Costs	20.93	-	-	-	11.76	-
Loss (Gain) From Sale of Investments	0.37	7.53	0.6	-0.31	-1.15	0.12
Stock-Based Compensation	28.64	32.46	35.71	18.44	15.43	16.21
Provision & Write-off of Bad Debts	2.41	2	0.82	2.1	0.44	0.2
Other Operating Activities	39.01	51.07	59.62	-2.02	32.8	1.26
Change in Accounts Receivable	-7.7	-9.53	-10.41	-6.74	-7.05	13.28
Change in Inventory	-5.2	-5.55	-58.05	-33.04	-10.21	-0.87
Change in Accounts Payable	0.15	-5.57	8.64	2.28	4.25	2.53
Change in Unearned Revenue	-	-	-	-4.79	-9.06	13.85
Change in Other Net Operating Assets	-4.71	1.39	5.86	-1.86	-13.46	-9.1
Operating Cash Flow	29.38	25.79	-45.75	-11.54	18.48	74.27
Operating Cash Flow Growth	-	-	-	-	-75.13%	131.86%
Capital Expenditures	-32.28	-34.88	-62.05	-23.16	-17.79	-22.73
Cash Acquisitions	-	-	29.42	-	-	-18
Sale (Purchase) of Intangibles	-	-	-	-	-1.81	-1.61
Investment in Securities	7.4	7.4	-	0.13	-2.17	-10
Other Investing Activities	0.02	-0.1	-0.5	-1.5	-1.25	-
Investing Cash Flow	-24.86	-27.58	-33.13	-24.53	-23.01	-52.33
Short-Term Debt Issued	-	-	-	-	-	100
Long-Term Debt Issued	-	197.6	174.5	-	-	-
Total Debt Issued	157.6	197.6	174.5	-	-	100
Short-Term Debt Repaid	-	-	-	-	-	-100
Long-Term Debt Repaid	-	-143.21	-106.55	-2.59	-0.54	-0.32
Total Debt Repaid	-128.25	-143.21	-106.55	-2.59	-0.54	-100.32
Net Debt Issued (Repaid)	29.36	54.39	67.95	-2.59	-0.54	-0.32
Issuance of Common Stock	6.04	6.26	5.13	4.34	8.82	7.6
Repurchase of Common Stock	-0.53	-5.31	-4.4	-1.73	-2.56	-2.49
Other Financing Activities	-6.53	-4.63	-3.36	-0.09	-9.35	-1.54
Financing Cash Flow	28.32	50.71	65.32	-0.08	-3.62	3.25
Foreign Exchange Rate Adjustments	0.55	-0.94	0.62	-1	-0.82	1.24
Net Cash Flow	33.39	47.98	-12.94	-37.15	-8.97	26.42
Free Cash Flow	-2.9	-9.09	-107.8	-34.7	0.69	51.55
Free Cash Flow Growth	-	-	-	-	-98.66%	384.65%
Free Cash Flow Margin	-0.35%	-1.14%	-14.44%	-7.53%	0.15%	12.68%
Free Cash Flow Per Share	-0.07	-0.24	-2.94	-1.73	0.04	2.66
Cash Interest Paid	16.9	16.9	5.8	1.4	1.5	1.9
Cash Income Tax Paid	1.3	1.3	0.9	-0.9	4.8	0.5
Levered Free Cash Flow	36.69	55.42	-140.87	-36.18	20.23	51.48
Unlevered Free Cash Flow	54.23	73.94	-135.48	-35.37	21.37	53.03
Change in Working Capital	-17.46	-19.25	-53.96	-44.14	-35.52	19.7

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q